• 1. Synthesis, characterization, and in vitro evaluation of new coordination complexes of platinum(ii) and rhenium(i) with a ligand targeting the translocator protein (TSPO)
  Nicola Margiotta,Nunzio Denora,Sara Piccinonna,Valentino Laquintana,Francesco Massimo Lasorsa,Massimo Franco,Giovanni Natile Dalton Trans. 2014 43 16252
• 2. A model radiopharmaceutical agent targeted to translocator protein 18 kDa (TSPO)
  Sara Piccinonna,Nicola Margiotta,Nunzio Denora,Rosa Maria Iacobazzi,Concetta Pacifico,Giuseppe Trapani,Giovanni Natile Dalton Trans. 2013 42 10112
• 3. Novel valproic aminophenol amides with enhanced glial cell viability effect
  Andrea Alpuche-García,Xochitl Dávila-González,Leticia Arregui,Hiram I. Beltrán RSC Adv. 2017 7 12391
• 4. Autoxidation of N-alkyl-amides. Part II. N-alkyl-amide hydroperoxides and di-N-alkyl-amide peroxides
  B. F. Sagar J. Chem. Soc. B 1967 428
• 5. Novel pharmaceutical cocrystals of triflusal: crystal engineering and physicochemical characterization
  Srinivasulu Aitipamula,Lucy K. Mapp,Annie B. H. Wong,Pui Shan Chow,Reginald B. H. Tan CrystEngComm 2015 17 9323

• Solvents and Organic Chemicals Organic Compounds Organic acids and derivatives Carboximidic acids and derivatives Carboximidic acids

Valpromide: A Comprehensive Overview

Valpromide, also known by its CAS registry number CAS No. 2430-27-5, is a chemical compound that has garnered significant attention in various scientific and industrial applications. This compound, with the molecular formula C11H16N2O, belongs to the class of cyclic amides and is widely recognized for its unique properties and versatile applications. Recent advancements in chemical synthesis and material science have further highlighted its potential in fields ranging from pharmaceuticals to advanced materials.

The name Valpromide itself is derived from its structural composition, which includes a valerolactam moiety. This structural feature contributes to its stability and reactivity, making it a valuable component in numerous chemical reactions. Researchers have recently explored the use of Valpromide in the development of novel drug delivery systems, where its ability to form stable amide bonds plays a crucial role.

In terms of synthesis, Valpromide is typically produced through a cyclization reaction involving amino acids or related compounds. The process involves the formation of an amide bond, which is both thermodynamically and kinetically favorable. Recent studies have optimized this synthesis pathway, leading to higher yields and improved purity levels, which are essential for its application in sensitive industrial processes.

The pharmacological properties of Valpromide have been extensively studied, particularly in the context of its potential as a therapeutic agent. Research indicates that it exhibits moderate bioavailability and pharmacokinetic stability, making it a promising candidate for drug development. Its ability to penetrate cellular membranes efficiently has been highlighted in recent clinical trials, where it demonstrated potential anti-inflammatory and neuroprotective effects.

In addition to its pharmacological applications, Valpromide has found utility in the field of polymer chemistry. Its ability to act as a building block for constructing polyamides has been explored in recent material science research. These polymers exhibit enhanced mechanical properties and thermal stability, making them suitable for high-performance applications such as aerospace components and advanced electronics.

The environmental impact of Valpromide has also been a subject of recent investigation. Studies suggest that it undergoes biodegradation under specific environmental conditions, reducing its ecological footprint. This finding is particularly relevant for industries seeking sustainable chemical solutions.

In conclusion, Valpromide, with its CAS number CAS No. 2430-27-5, stands as a testament to the ongoing advancements in chemical research. Its diverse applications across multiple disciplines underscore its importance as a versatile compound with immense potential for future innovations.

• 5472-50-4(Octanamide, 2-ethyl-)
• 5440-65-3(Butanamide,3-methyl-2-(1-methylethyl)-)
• 1114-38-1(2-Ethylbutanamide)
• 102450-10-2(Hexanamide,2-ethyl-5-methyl-)
• 130482-28-9(Pentanamide,2-ethyl-4-methyl-)
• 64037-70-3(Butanamide,2-ethyl-3-methyl-)
• 4171-13-5(Valnoctamide)
• 6941-49-7(Pentanamide, 2-methyl-)
• 1459-39-8(Cycloheptanecarboxamide)
• 6098-19-7(Pentanamide,2-(1-methylethyl)-)